- Filed
- May 14, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · May 7, 2021 | 133.55M sh |
| Cash And Equivalents | Q1 2021 · Mar 31, 2021 | $207.61K |
| Cash And Equivalents | Q1 2021 · Dec 31, 2020 | $427.9K |
| Current Liabilities | Q1 2021 · Mar 31, 2021 | $431.75K |
| Current Liabilities | Q1 2021 · Dec 31, 2020 | $399.58K |
| Total Liabilities | Q1 2021 · Mar 31, 2021 | $3.44M |
| Total Liabilities | Q1 2021 · Dec 31, 2020 | $3.38M |
| Current Assets | Q1 2021 · Mar 31, 2021 | $250.86K |
| Current Assets | Q1 2021 · Dec 31, 2020 | $477.81K |
| Total Assets | Q1 2021 · Mar 31, 2021 | $315.44K |
| Total Assets | Q1 2021 · Dec 31, 2020 | $551.79K |
| Shares Diluted | Q1 2021 · Mar 31, 2020 | 133.1M sh |
| Operating Cash Flow | Q1 2021 · Mar 31, 2020 | −$267.05K |
| Stockholders Equity | Q1 2021 · Mar 31, 2020 | −$2.44M |
| Stockholders Equity | Q1 2021 · Dec 31, 2019 | −$2.34M |
| Eps Diluted | Q1 2021 · Mar 31, 2020 | $0.00 |
| Eps Basic | Q1 2021 · Mar 31, 2020 | $0.00 |
| Sga Expense restated | Q1 2021 · Mar 31, 2020 | $356.86K |
| Rd Expense restated | Q1 2021 · Mar 31, 2020 | $475 |
| Net Income | Q1 2021 · Mar 31, 2020 | −$386.73K |
| Operating Income | Q1 2021 · Mar 31, 2020 | −$338.15K |
| Revenue | Q1 2021 · Mar 31, 2020 | $19.19K |